A 48-year-old female from Delhi is found to have HBsAg positivity on routine blood screening during a health checkup. She is asymptomatic with normal liver function tests (ALT 35 IU/L, AST 32 IU/L, albumin 4.2 g/dL). Further serological testing shows: HBsAg positive, anti-HBc IgG positive, anti-HBc IgM negative, HBeAg negative, anti-HBe positive, anti-HBs negative. HBV DNA is undetectable by PCR. What is the most appropriate interpretation?

Explanation

## Interpretation of Occult/Low-Replicative Chronic HBV **Key Point:** This serological profile represents chronic hepatitis B in the **immune control phase** (also called the **low-replicative or inactive carrier state**). ### Serological Profile Breakdown | Marker | Result | Interpretation | |--------|--------|----------------| | HBsAg | Positive | **Indicates chronic HBV** (persists >6 months) | | Anti-HBc IgG | Positive | Confirms past/chronic infection (not acute) | | Anti-HBc IgM | Negative | **Rules out acute infection** — IgM disappears by 6 months | | HBeAg | Negative | Low viral replication phase | | Anti-HBe | Positive | Seroconversion to anti-HBe; associated with lower HBV DNA | | Anti-HBs | Negative | Indicates ongoing HBsAg production; not immune | | HBV DNA | Undetectable | Viral load <20 IU/mL; minimal active replication | ### Clinical Context **High-Yield:** This is the **"inactive HBsAg carrier" state** — a stable phase of chronic HBV characterized by: - Persistent HBsAg (>6 months) - Normal or near-normal ALT - Undetectable or very low HBV DNA - HBeAg-negative, anti-HBe-positive status - Minimal risk of progression to cirrhosis (if ALT remains normal) **Clinical Pearl:** Approximately 70–80% of HBsAg-positive individuals worldwide are in this inactive carrier state. They have excellent long-term prognosis if ALT remains normal and HBV DNA remains undetectable. ### Why This Is NOT Acute Infection 1. **Anti-HBc IgM is negative** — acute infection would have IgM positivity 2. **Normal transaminases** — acute hepatitis presents with markedly elevated ALT/AST 3. **HBeAg-negative status** — indicates chronic phase, not acute replication 4. **Undetectable HBV DNA** — acute infection shows high viral load **Mnemonic — HBV Phases:** **"HBeAg+ = Replicative; HBeAg− Anti-HBe+ = Control Phase"** — the transition from HBeAg-positive to HBeAg-negative (seroconversion) marks entry into the immune control phase. ## Management - **Monitor:** ALT and HBV DNA annually; ultrasound for HCC screening if cirrhosis present - **Antiviral therapy:** Generally NOT indicated in inactive carriers with normal ALT and undetectable HBV DNA - **Vaccination:** Household contacts and sexual partners should be vaccinated - **Counseling:** Low transmission risk if ALT normal; avoid alcohol and hepatotoxins